insights_auto
Why is AVBP down 4.69%?
Dive Deeperchevron_right
AVBP:NASDAQ
Arrivent Biopharma Inc
$12.40
arrow_downward
-4.69%(-0.61) 1D
Nov 16, 11:47:49 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVBP...
Open
$12.86
High
$13.14
Low
$12.38
Mkt. cap
641.37M
Avg. vol.
2.14M
Volume
106.13K
52-wk high
$35.83
52-wk low
$11.37
EPS
-$3.65
Shares outstanding
51.72M
No. of employees
77
Open
$12.86
High
$13.14
Low
$12.38
Mkt. cap
641.37M
Avg. vol.
2.14M
Volume
106.13K
52-wk high
$35.83
52-wk low
$11.37
EPS
-$3.65
Shares outstanding
51.72M
No. of employees
77
News stories
From web sources and news partners
GuruFocus
·
1 hour ago
AVBP Maintained by Guggenheim -- Price Target Lowered to $28.00
Investing.com
·
2 hours ago
Guggenheim lowers ArriVent BioPharma stock price target to $28
Seeking Alpha
·
1 day ago
ArriVent BioPharma: ARR-217 Gives Us A Reason To Reconsider Our Strong Sell (Rating Upgrade)
About Arrivent Biopharma Inc
CEO-
Employees77
Founded2021
HeadquartersNewtown Square, Pennsylvania, United States
SectorHealth Care
IndustryBiotechnology
Websitearrivent.com